Details for 2014726731
Up to date per 03.04.2026
Actions
Details for 2014726731
Granted/Registered
European Patent
30.03.2016 A
29.06.2022 B1
22.05.2013
GB
201309248
11.03.2014
GB
201404301
C07K 7/62 20060101AFI20151117BHEP
Owner
Spero Therapeutics, Inc.675 Massachusetts Avenue, 14th Floor Cambridge, MA 02139US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
BROWN, PamelaCantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 8LSGB
DAWSON, MichaelCantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 8LSGB
SIMONOVIC, MonaCantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 8LSGB
BOAKES, StevenCantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 8LSGB
DUPERCHY, EstherCantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 8LSGB
Information about Fees